Sessions by Day

Sunday, 6 December 2015

Plenary sessions

Time

Title

Room

09:00 – 10:00

Taxing health-harming products and creating health promotion funds: A win-win health strategy for governments: Panel Discussion (tc, ncds, cs)

Auditorium I

15:15 – 16:15

Closing Session (tb, clh, cs, hiv, lh, mdr-tb, ncds, naps, tc, zoo, res)

Auditorium I

Symposia

Time

Title

Room

10:30 – 12:00

53. Fighting TB in the post-2015 era: paradigm shift in strategies and plans to put an end to TB | en français (cs, tb)

Auditorium I

10:30 – 12:00

54. Critical updates on the treatment of TB-HIV co-infected children (clh, hiv, tb)

MR 2.44-2.46

10:30 – 12:00

55. Why are DR-TB patients lost by TB programmes? Patients’ perspective on how to address DR-TB treatment adherence (mdr-tb)

MR 2.61-2.63

10:30 – 12:00

56. The relationship between gender and specific tobacco products, tobacco consumption and inequalities (tc)

Ballroom East-Westin

10:30 – 12:00

57. The role of cost-effectiveness in achieving the End TB Strategy (tb)

Ballroom West-Westin

10:30 – 12:00

58. Universal health coverage and insurance: how TB fits into the health financing picture (tb)

Da Gama/Diaz-Westin

13:30 – 15:00

59. HIV/TB Late-Breaker Session | en français (hiv, tb, res)

Auditorium I

13:30 – 15:00

60. Moving past clinic-based care: practical steps to improve TB care through community engagement | en français (cs, tb)

Ballroom East-CTICC

13:30 – 15:00

61. Progress in clinical trials for TB treatment: 2015 (res, tb)

Roof Terrace

13:30 – 15:00

62. Innovative approach to improving access and quality of care for DR-TB: implementing the ECHO telehealth model (mdr-tb, tb)

Auditorium II

63. See 5 December

13:30 – 15:00

64. TB contact investigation in high-risk populations: innovative approaches and implementation experiences (tb)

Ballroom East-Westin

13:30 – 15:00

65. The XDR experience: clinician and patient perspectives on treatment and care (cs, mdr-tb, tb)

Ballroom West-Westin

E-poster sessions

Time

Title

Room

12:15 – 13:15

11. m-health solutions (tb)

Poster Area

12:15 – 13:15

12. Pneumonia and indoor air pollution (ncds, lh)

Poster Area

12:15 – 13:15

13. Case finding and contact tracing (tb)

Poster Area

12:15 – 13:15

14. Sniffing out TB: from nose to immunochemistry (tb)

Poster Area

12:15 – 13:15

15. From TB diagnosis to outcomes, and everything in between (tb, hiv)

Poster Area

Poster discussion sessions

Time

Title

Room

12:15 – 13:15

50. TB tidbits: diagnosis, surgery and outcomes (tb)

Poster Area

12:15 – 13:15

51. M/XDR treatment: toxicity and stigma (mdr-tb, tb)

Poster Area

12:15 – 13:15

52. Community-based and self-administered treatment of drug-resistant TB (mdr-tb, tb)

Poster Area

12:15 – 13:15

53. Infection control (tb)

Poster Area

12:15 – 13:15

54. TB and nutrition (tb)

Poster Area

12:15 – 13:15

55. Molecular epidemiology and modelling: how can we break the cycle of transmission? (tb)

Poster Area

12:15 – 13:15

56. Tbilisi to Lima: a journey through TB treatment outcomes (tb)

Poster Area

12:15 – 13:15

57. When the tail wags the dog: drug resistance in TB programmes (mdr-tb, tb)

Poster Area

12:15 – 13:15

58. Advancing the END TB strategy and other policy issues (tb)

Poster Area

12:15 – 13:15

59. Basic science: host (tb)

Poster Area

12:15 – 13:15

60. Imagining and prediction rules for TB diagnosis (tb)

Poster Area

12:15 – 13:15

61. Alternative diagnostics for drug resistance (mdr-tb, tb)

Poster Area

12:15 – 13:15

62. Insights into drug-resistant tuberculosis from Ghana to Peru (mdr-tb, tb)

Poster Area

12:15 – 13:15

63. MDR-TB: detection, prevalence, and drivers (mdr-tb, tb)

Poster Area

12:15 – 13:15

64. Patient-centered care and methods to improve treatment adherence (tb)

Poster Area

12:15 – 13:15

65. Why are you late? Delay in treatment access (tb)

Poster Area

12:15 – 13:15

66. Gender issues in TB and tobacco (tb, tc)

Poster Area

12:15 – 13:15

67. The spectrum of life: miners, drug users, the elderly (tb)

Poster Area

12:15 – 13:15

68. Paediatric TB: IPT, contact tracing and child perspectives (clh, tb)

Poster Area

12:15 – 13:15

69. Paediatric TB: epidemiology - II (clh, tb)

Poster Area

12:15 – 13:15

70. The 2 'Ts': linking TB and tobacco (tc, tb)

Poster Area

12:15 – 13:15

71. From old to new: shisha to e-cigarettes (tc)

Poster Area

12:15 – 13:15

72. Holding hands: high-level cooperation on tobacco control (tc)

Poster Area

12:15 – 13:15

73. IPT: attitudes, application and adherence (hiv, tb)

Poster Area

Oral abstract sessions

Time

Title

Room

10:30 – 12:00

21. TB epidemiology: post and future insights into case finding, drug resistance | en français (mdr-tb, tb)

Ballroom East-CTICC

13:30 – 15:00

22. The nature of the beast: emerging molecular information about mycobacteria (res, tb)

Ballroom West-CTICC

13:30 – 15:00

23. TB in children, including MDR (clh, mdr-tb, tb)

MR 2.44 - 2.46

13:30 – 15:00

24. The wide swath of vulnerable populations (cs)

MR 2.61 - 2.63

13:30 – 15:00

25. Engagement of CSOs, communities and patients in TB management and control (cs, tb)

MR 2.64 - 2.66

13:30 – 15:00

26. Lung health: pneumonia, COPD, asthma and cystic fibrosis (lh, ncds)

Da Gama/Diaz-Westin

Short Oral Abstract Session

Time

Title

Room

10:30 – 12:00

01. Across the spectrum of TB management (mdr-tb, tb)

Roof Terrace

10:30 – 12:00

02. How to reach the END of TB (tb)

Auditorium II

10:30 – 12:00

03. HIV and TB: snapshots (hiv, tb)

Ballroom West-CTICC

10:30 – 12:00

04. TB epidemiology: from Malawi to Taiwan (tb)

MR 2.41-2.43

10:30 – 12:00

05. Training for the fight against TB (mdr-tb, tb)

MR 2.64-2.66

Meet-the-expert sessions

Time

Title

Room

08:00 – 08:50

6. Advocacy and advocates: What is it? Who are they? - Muyabala Munachitombwe-Muna (Swaziland), Evaline Kibuchi (Kenya) (cs)

MR 2.44–2.46

08:00 – 08:50

7. Tuberculosis infection control - Virginia Lipke (Switzerland), Max Meis (Netherlands) (tb)

MR 2.61–2.63

08:00 – 08:50

8. Highlights and updates of diagnostic research for tuberculosis: where are we, what next? – Grant Theron (South Africa) (tb, res)

MR 2.64–2.66

08:00 – 08:50

2.2 From the recent literature on HIV – Robin Wood (South Africa) (hiv)

Social events

Time

Title

Room

Closing reception

Ceremony

Time

Title

Room

Closing Ceremony

Union meetings

Time

Title

Room

10:00 – 13:00

Board Meeting (2)

MR 1.41–1.42

Sessions by Day

Topics Legend